Filing Flows › Inogen (INGN) › Q3 2026 › vs Q3 2025
Inogen (INGN) Q3 2026 vs Q3 2025 (year over year)
Inogen's revenue fell $1.9M (-2%) from $79.1M in Q3 2025 to $77.2M in Q3 2026.
Inogen, Q3 2026: revenue $77.2M (-2% year over year), operating margin -20.2%, net loss $16.2M, operating cash flow −$4.5M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $77.2M | $79.1M | −$1.9M | -2% |
| Net loss | $16.2M | $5.3M | $10.9M | +205% |
| Costs & expenses | $93.3M | $84.5M | $8.8M | +10% |
| Operating costs | $92.8M | $84.5M | $8.3M | +10% |
| Interest & other, net | $418K | $5K | $413K | 84× |
| Income tax | $153K | −$146K | $299K | — |
| Cost of revenue | $43.2M | $42.9M | $260K | +0.6% |
| Research & development | $5.4M | $4.8M | $564K | +12% |
| Sales & marketing | $18.9M | $20.6M | −$1.7M | -8% |
| General & admin | $14.7M | $16.1M | −$1.4M | -9% |
| Operating cash sources | $16.2M | $5.3M | $10.9M | +205% |
| Share-based compensation | $1.7M | $1.7M | $13K | +0.8% |
| Working capital & other | $10.0M | $5.8M | $4.2M | +73% |
| Cash used in operations | $4.5M | −$2.2M | $6.6M | — |
| Net loss absorbed | $16.2M | $5.3M | $10.9M | +205% |
Questions
How much did Inogen's revenue grow year over year in Q3 2026?
Inogen's revenue fell $1.9M (-2%) from $79.1M in Q3 2025 to $77.2M in Q3 2026.